26 June 2017
Int J Med Sci 2017; 14(2):123-127. doi:10.7150/ijms.17321
Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum
1. Department of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.
Keywords: Estriol, pregnancy outcomes, gestational diabetes.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Hur J, Cho EH, Baek KH, Lee KJ. Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int J Med Sci 2017; 14(2):123-127. doi:10.7150/ijms.17321. Available from http://www.medsci.org/v14p0123.htm